Global Biologics Drug Discovery Market Research Report 2023

The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.

The global Biologics Drug Discovery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Biologics Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Biologics Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Biologics Drug Discovery in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Biologics Drug Discovery include GenScript, Roche, Pfizer, Novartis, Sanofi, Merck, GlaxoSmithKline, AstraZeneca and AbbVie, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biologics Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Drug Discovery.

The Biologics Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics Drug Discovery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biologics Drug Discovery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Biologicals

1.2.3 Monoclonal Antibodies

1.2.4 Recombinant Proteins

1.2.5 Other Biologics

1.3 Market by Application

1.3.1 Global Biologics Drug Discovery Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Labs

1.3.5 Diagnostic Centers

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Biologics Drug Discovery Market Perspective (2018-2029)

2.2 Biologics Drug Discovery Growth Trends by Region

2.2.1 Global Biologics Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biologics Drug Discovery Historic Market Size by Region (2018-2023)

2.2.3 Biologics Drug Discovery Forecasted Market Size by Region (2024-2029)

2.3 Biologics Drug Discovery Market Dynamics

2.3.1 Biologics Drug Discovery Industry Trends

2.3.2 Biologics Drug Discovery Market Drivers

2.3.3 Biologics Drug Discovery Market Challenges

2.3.4 Biologics Drug Discovery Market Restraints

3.1 Global Top Biologics Drug Discovery Players by Revenue

3.1.1 Global Top Biologics Drug Discovery Players by Revenue (2018-2023)

3.1.2 Global Biologics Drug Discovery Revenue Market Share by Players (2018-2023)

3.2 Global Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biologics Drug Discovery Revenue

3.4 Global Biologics Drug Discovery Market Concentration Ratio

3.4.1 Global Biologics Drug Discovery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Discovery Revenue in 2022

3.5 Biologics Drug Discovery Key Players Head office and Area Served

3.6 Key Players Biologics Drug Discovery Product Solution and Service

3.7 Date of Enter into Biologics Drug Discovery Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Biologics Drug Discovery Historic Market Size by Type (2018-2023)

4.2 Global Biologics Drug Discovery Forecasted Market Size by Type (2024-2029)

5.1 Global Biologics Drug Discovery Historic Market Size by Application (2018-2023)

5.2 Global Biologics Drug Discovery Forecasted Market Size by Application (2024-2029)

6.1 North America Biologics Drug Discovery Market Size (2018-2029)

6.2 North America Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biologics Drug Discovery Market Size by Country (2018-2023)

6.4 North America Biologics Drug Discovery Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Biologics Drug Discovery Market Size (2018-2029)

7.2 Europe Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biologics Drug Discovery Market Size by Country (2018-2023)

7.4 Europe Biologics Drug Discovery Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Biologics Drug Discovery Market Size (2018-2029)

8.2 Asia-Pacific Biologics Drug Discovery Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biologics Drug Discovery Market Size by Region (2018-2023)

8.4 Asia-Pacific Biologics Drug Discovery Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Biologics Drug Discovery Market Size (2018-2029)

9.2 Latin America Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biologics Drug Discovery Market Size by Country (2018-2023)

9.4 Latin America Biologics Drug Discovery Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Biologics Drug Discovery Market Size (2018-2029)

10.2 Middle East & Africa Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biologics Drug Discovery Market Size by Country (2018-2023)

10.4 Middle East & Africa Biologics Drug Discovery Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GenScript

11.1.1 GenScript Company Detail

11.1.2 GenScript Business Overview

11.1.3 GenScript Biologics Drug Discovery Introduction

11.1.4 GenScript Revenue in Biologics Drug Discovery Business (2018-2023)

11.1.5 GenScript Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Biologics Drug Discovery Introduction

11.2.4 Roche Revenue in Biologics Drug Discovery Business (2018-2023)

11.2.5 Roche Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Biologics Drug Discovery Introduction

11.3.4 Pfizer Revenue in Biologics Drug Discovery Business (2018-2023)

11.3.5 Pfizer Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Biologics Drug Discovery Introduction

11.4.4 Novartis Revenue in Biologics Drug Discovery Business (2018-2023)

11.4.5 Novartis Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Biologics Drug Discovery Introduction

11.5.4 Sanofi Revenue in Biologics Drug Discovery Business (2018-2023)

11.5.5 Sanofi Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Biologics Drug Discovery Introduction

11.6.4 Merck Revenue in Biologics Drug Discovery Business (2018-2023)

11.6.5 Merck Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Detail

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Biologics Drug Discovery Introduction

11.7.4 GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2018-2023)

11.7.5 GlaxoSmithKline Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Biologics Drug Discovery Introduction

11.8.4 AstraZeneca Revenue in Biologics Drug Discovery Business (2018-2023)

11.8.5 AstraZeneca Recent Development

11.9 AbbVie

11.9.1 AbbVie Company Detail

11.9.2 AbbVie Business Overview

11.9.3 AbbVie Biologics Drug Discovery Introduction

11.9.4 AbbVie Revenue in Biologics Drug Discovery Business (2018-2023)

11.9.5 AbbVie Recent Development

11.10 Amgen

11.10.1 Amgen Company Detail

11.10.2 Amgen Business Overview

11.10.3 Amgen Biologics Drug Discovery Introduction

11.10.4 Amgen Revenue in Biologics Drug Discovery Business (2018-2023)

11.10.5 Amgen Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Detail

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Biologics Drug Discovery Introduction

11.11.4 Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2018-2023)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Novo Nordisk

11.12.1 Novo Nordisk Company Detail

11.12.2 Novo Nordisk Business Overview

11.12.3 Novo Nordisk Biologics Drug Discovery Introduction

11.12.4 Novo Nordisk Revenue in Biologics Drug Discovery Business (2018-2023)

11.12.5 Novo Nordisk Recent Development

11.13 Allergan

11.13.1 Allergan Company Detail

11.13.2 Allergan Business Overview

11.13.3 Allergan Biologics Drug Discovery Introduction

11.13.4 Allergan Revenue in Biologics Drug Discovery Business (2018-2023)

11.13.5 Allergan Recent Development

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Detail

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Biologics Drug Discovery Introduction

11.14.4 Astellas Pharma Revenue in Biologics Drug Discovery Business (2018-2023)

11.14.5 Astellas Pharma Recent Development

11.15 Teva Pharmaceutical Industries

11.15.1 Teva Pharmaceutical Industries Company Detail

11.15.2 Teva Pharmaceutical Industries Business Overview

11.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Introduction

11.15.4 Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2018-2023)

11.15.5 Teva Pharmaceutical Industries Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Biologics Drug Discovery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Biologicals

    Table 3. Key Players of Monoclonal Antibodies

    Table 4. Key Players of Recombinant Proteins

    Table 5. Key Players of Other Biologics

    Table 6. Global Biologics Drug Discovery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Biologics Drug Discovery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Biologics Drug Discovery Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Biologics Drug Discovery Market Share by Region (2018-2023)

    Table 10. Global Biologics Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Biologics Drug Discovery Market Share by Region (2024-2029)

    Table 12. Biologics Drug Discovery Market Trends

    Table 13. Biologics Drug Discovery Market Drivers

    Table 14. Biologics Drug Discovery Market Challenges

    Table 15. Biologics Drug Discovery Market Restraints

    Table 16. Global Biologics Drug Discovery Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Biologics Drug Discovery Market Share by Players (2018-2023)

    Table 18. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2022)

    Table 19. Ranking of Global Top Biologics Drug Discovery Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Biologics Drug Discovery Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Biologics Drug Discovery Product Solution and Service

    Table 23. Date of Enter into Biologics Drug Discovery Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Biologics Drug Discovery Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Biologics Drug Discovery Revenue Market Share by Type (2018-2023)

    Table 27. Global Biologics Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Biologics Drug Discovery Revenue Market Share by Type (2024-2029)

    Table 29. Global Biologics Drug Discovery Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Biologics Drug Discovery Revenue Market Share by Application (2018-2023)

    Table 31. Global Biologics Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Biologics Drug Discovery Revenue Market Share by Application (2024-2029)

    Table 33. North America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Biologics Drug Discovery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Biologics Drug Discovery Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Biologics Drug Discovery Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)

    Table 48. GenScript Company Detail

    Table 49. GenScript Business Overview

    Table 50. GenScript Biologics Drug Discovery Product

    Table 51. GenScript Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 52. GenScript Recent Development

    Table 53. Roche Company Detail

    Table 54. Roche Business Overview

    Table 55. Roche Biologics Drug Discovery Product

    Table 56. Roche Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 57. Roche Recent Development

    Table 58. Pfizer Company Detail

    Table 59. Pfizer Business Overview

    Table 60. Pfizer Biologics Drug Discovery Product

    Table 61. Pfizer Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 62. Pfizer Recent Development

    Table 63. Novartis Company Detail

    Table 64. Novartis Business Overview

    Table 65. Novartis Biologics Drug Discovery Product

    Table 66. Novartis Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 67. Novartis Recent Development

    Table 68. Sanofi Company Detail

    Table 69. Sanofi Business Overview

    Table 70. Sanofi Biologics Drug Discovery Product

    Table 71. Sanofi Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 72. Sanofi Recent Development

    Table 73. Merck Company Detail

    Table 74. Merck Business Overview

    Table 75. Merck Biologics Drug Discovery Product

    Table 76. Merck Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 77. Merck Recent Development

    Table 78. GlaxoSmithKline Company Detail

    Table 79. GlaxoSmithKline Business Overview

    Table 80. GlaxoSmithKline Biologics Drug Discovery Product

    Table 81. GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 82. GlaxoSmithKline Recent Development

    Table 83. AstraZeneca Company Detail

    Table 84. AstraZeneca Business Overview

    Table 85. AstraZeneca Biologics Drug Discovery Product

    Table 86. AstraZeneca Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 87. AstraZeneca Recent Development

    Table 88. AbbVie Company Detail

    Table 89. AbbVie Business Overview

    Table 90. AbbVie Biologics Drug Discovery Product

    Table 91. AbbVie Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 92. AbbVie Recent Development

    Table 93. Amgen Company Detail

    Table 94. Amgen Business Overview

    Table 95. Amgen Biologics Drug Discovery Product

    Table 96. Amgen Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 97. Amgen Recent Development

    Table 98. Bristol-Myers Squibb Company Detail

    Table 99. Bristol-Myers Squibb Business Overview

    Table 100. Bristol-Myers Squibb Biologics Drug Discovery Product

    Table 101. Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 102. Bristol-Myers Squibb Recent Development

    Table 103. Novo Nordisk Company Detail

    Table 104. Novo Nordisk Business Overview

    Table 105. Novo Nordisk Biologics Drug Discovery Product

    Table 106. Novo Nordisk Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 107. Novo Nordisk Recent Development

    Table 108. Allergan Company Detail

    Table 109. Allergan Business Overview

    Table 110. Allergan Biologics Drug Discovery Product

    Table 111. Allergan Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 112. Allergan Recent Development

    Table 113. Astellas Pharma Company Detail

    Table 114. Astellas Pharma Business Overview

    Table 115. Astellas Pharma Biologics Drug Discovery Product

    Table 116. Astellas Pharma Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 117. Astellas Pharma Recent Development

    Table 118. Teva Pharmaceutical Industries Company Detail

    Table 119. Teva Pharmaceutical Industries Business Overview

    Table 120. Teva Pharmaceutical Industries Biologics Drug Discovery Product

    Table 121. Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)

    Table 122. Teva Pharmaceutical Industries Recent Development

    Table 123. Research Programs/Design for This Report

    Table 124. Key Data Information from Secondary Sources

    Table 125. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Biologics Drug Discovery Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Biologics Drug Discovery Market Share by Type: 2022 VS 2029

    Figure 3. Biologicals Features

    Figure 4. Monoclonal Antibodies Features

    Figure 5. Recombinant Proteins Features

    Figure 6. Other Biologics Features

    Figure 7. Global Biologics Drug Discovery Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Biologics Drug Discovery Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Research Labs Case Studies

    Figure 12. Diagnostic Centers Case Studies

    Figure 13. Others Case Studies

    Figure 14. Biologics Drug Discovery Report Years Considered

    Figure 15. Global Biologics Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Biologics Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Biologics Drug Discovery Market Share by Region: 2022 VS 2029

    Figure 18. Global Biologics Drug Discovery Market Share by Players in 2022

    Figure 19. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Biologics Drug Discovery Revenue in 2022

    Figure 21. North America Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Biologics Drug Discovery Market Share by Country (2018-2029)

    Figure 23. United States Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Biologics Drug Discovery Market Share by Country (2018-2029)

    Figure 27. Germany Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Biologics Drug Discovery Market Share by Region (2018-2029)

    Figure 35. China Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Biologics Drug Discovery Market Share by Country (2018-2029)

    Figure 43. Mexico Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Biologics Drug Discovery Market Share by Country (2018-2029)

    Figure 47. Turkey Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. GenScript Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 50. Roche Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 51. Pfizer Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 52. Novartis Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 53. Sanofi Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 54. Merck Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 55. GlaxoSmithKline Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 56. AstraZeneca Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 57. AbbVie Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 58. Amgen Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 60. Novo Nordisk Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 61. Allergan Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 62. Astellas Pharma Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed